CNTX
Context Therapeutics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No thesis.
—
Fund move
Fund move
Context Therapeutics Inc.
0.20
0.00 · −0.55%
post 0.19 −3.74%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Nextech InvestNextech Invest | $4.1M | 11.81% | 0.00% | |
| 2 | Deep Track CapitalDeep Track Capital | $4.1M | 11.81% | 0.00% | |
| 3 | Soleus Capital ManagementSoleus | $3.9M | 11.25% | +1.44% | |
| 4 | BlackRockBlackRockindex-like | $3.4M | 9.82% | +628.63% | |
| 5 | Avidity Partners ManagementAvidity Partners | $2.8M | 7.96% | −50.00% | |
| 6 | Franklin ResourcesFranklin Resources | $2.1M | 6.06% | 0.00% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $1.9M | 5.47% | 0.00% | |
| 8 | Octagon Capital AdvisorsOctagon Capital | $1.7M | 4.86% | −41.90% | |
| 9 | Blue Owl Capital HoldingsBlue Owl Capital | $1.6M | 4.67% | −42.35% | |
| 10 | TCG Crossover ManagementTCG Crossover | $1.5M | 4.27% | 0.00% | |
| 11 | Geode Capital ManagementGeodeindex-like | $1.0M | 2.91% | +203.15% | |
| 12 | State StreetState Streetindex-like | $782,898 | 2.25% | +505.30% | |
| 13 | MPM Oncology Impact ManagementMPM Oncology Impact | $719,542 | 2.07% | −87.84% | |
| 14 | Renaissance TechnologiesRenaissance Technologies | $576,831 | 1.66% | +469.07% | |
| 15 | Acadian Asset ManagementAcadian | $560,000 | 1.61% | new | |
| 16 | ADAR1 Capital ManagementADAR1 | $415,962 | 1.20% | +113.89% | |
| 17 | Jane Street GroupJane Street | $357,382 | 1.03% | +47.67% | |
| 18 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $353,938 | 1.02% | new | |
| 19 | Northern TrustNorthern Trustindex-like | $340,967 | 0.98% | +496.16% | |
| 20 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $240,374 | 0.69% | +27.11% | |
| 21 | Marshall WaceMarshall Wace | $211,490 | 0.61% | −86.96% | |
| 22 | XTX TopcoXTX Topco | $163,013 | 0.47% | new | |
| 23 | Qube Research & TechnologiesQube Research & Technologies | $142,390 | 0.41% | +2155.38% | |
| 24 | Charles Schwab Investment ManagementCharles Schwabindex-like | $126,206 | 0.36% | new | |
| 25 | Pathstone HoldingsPathstone | $119,019 | 0.34% | +94.91% |
79 managers report $34.8M of Context Therapeutics on form 13F for the quarter ended Jun 30 '26. 11 of them hold 80% of it; Nextech Invest is largest at 11.81%.
Expected move
No implied move.
No implied move.
No implied move.